Ronald A Williams
CIK 1185243 · Chairman · last filed 2026-06-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
EVHC price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
6TH FLOOR EAST
NEW YORK, NY 10013
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| WRBY | Director | 122,802 | $24.99 | $3.07M | $0 | 7 | 2026-06-10 |
| AGL | Director | 149,141 | $88.83 | $13.25M | $0 | 7 | 2026-06-04 |
| BA | Director | 4,200 | $191.42 | $804.0K | $300.6K | 54 | 2024-04-03 |
| JNJ | Director | 3,650 | $253.79 | $926.3K | $0 | 35 | 2022-02-17 |
| AXP | Director | 59,125 | $316.41 | $18.71M | $2.75M | 77 | 2021-10-04 |
| Envision Healthcare Corp (EVHC) Delisted | Director | 182,573 | — | — | -$4.30M | 16 | 2017-05-30 |
Recent Filings · Page 3 of 21
206 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-04-20 | AGL | Grant (A) | +6,936 | $0 | EDGAR |
| 2022-04-05 | BA | Grant (A) | — | $0 | EDGAR |
| 2022-02-17 | JNJ | Grant (A) | — | $0 | EDGAR |
| 2022-01-05 | BA | Grant (A) | — | $0 | EDGAR |
| 2021-10-05 | BA | Grant (A) | — | $0 | EDGAR |
| 2021-10-04 | AXP | Grant (A) | — | $0 | EDGAR |
| 2021-07-06 | BA | Grant (A) | — | $0 | EDGAR |
| 2021-07-02 | AXP | Grant (A) | — | $0 | EDGAR |
| 2021-05-06 | AXP | Grant (A) | — | $0 | EDGAR |
| 2021-04-16 | AGL | Grant (A) | +6,956 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.